SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,722,509 | -65.8% | 74,503 | -61.2% | 0.01% | -66.7% |
| Q2 2023 | $5,040,795 | -44.2% | 192,250 | -45.2% | 0.02% | -46.7% |
| Q1 2023 | $9,029,438 | +6.1% | 350,794 | +7.2% | 0.04% | -4.3% |
| Q4 2022 | $8,512,293 | -33.8% | 327,270 | -27.4% | 0.05% | -31.9% |
| Q3 2022 | $12,867,000 | +18.2% | 450,994 | +2.0% | 0.07% | +23.2% |
| Q2 2022 | $10,890,000 | +893.6% | 442,332 | +2178.4% | 0.06% | +833.3% |
| Q1 2022 | $1,096,000 | +117.0% | 19,414 | +138.2% | 0.01% | +100.0% |
| Q4 2021 | $505,000 | -38.6% | 8,152 | -37.2% | 0.00% | -40.0% |
| Q3 2021 | $823,000 | -81.3% | 12,978 | -75.7% | 0.01% | -83.9% |
| Q2 2021 | $4,410,000 | +15.8% | 53,516 | +3.4% | 0.03% | +10.7% |
| Q1 2021 | $3,808,000 | +339.2% | 51,757 | +332.9% | 0.03% | +300.0% |
| Q4 2020 | $867,000 | – | 11,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |